
German HTGF IV fund closes at €493m
Alongside the Federal Ministry of Economics and Climate Protection (BMWK) and KfW Capital, 45 private investors (companies) participated in HTGF IV...

DiogenX SA raises €27.5M in Series A financing
The Marseille-based specialist for beta cell regeneration announced it want to use the proceeds to advance its first-in-class regenerative treatment...

VectivBio taken over in $1bn acquisition
VectivBio Holding AG has entered into a acquisition agreement with Ironwood Pharmaceuticals Inc. Ironwood will launch a tender offer to buy...

LSP Dementia Fund closes at €260m
Investors included the Alzheimer’s Association, the European Investment Fund EIF, several unnamed global pharmaceutical, and insurance companies,...

Mainz Biomed Partners with Microba Life Sciences
Leveraging a platform for measuring the human gut microbiome to discover and develop novel therapeutics for major diseases, Microba and Mainz Biomed...

Neogap Therapeutics A/S partners with Cellerys AG
Stockholm based Neogap Therapeutics AB has partnered with Zurich-based Cellerys AG to provide its EpiTCer® platform within Celleris upcoming...